John Ormiston

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

Patrick W Serruys, Ben van Hout, Hans Bonnier et al. · The Lancet · 1998 · 655 citations

Medicine, Cardiology, Surgery +15

A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis

Patrick W. Serruys, John Ormiston, Robert‐Jan van Geuns et al. · Journal of the American College of Cardiology · 2016 · 160 citations · Full text

Medicine, Bioengineering, Cardiology +14

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.

Ian T. Meredith, John Ormiston, Robert Whitbourn et al. · PubMed · 2005 · 141 citations

Medicine, Cardiology, Surgery +17

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

Yosinobu Onuma, Patrick W. Serruys, John Ormiston et al. · EuroIntervention · 2010 · 129 citations

Medicine, Biomedical Engineering, Cardiology +16

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

Dariusz Dudek, Yoshinobu Onuma, John Ormiston et al. · EuroIntervention · 2012 · 126 citations · Full text

Medicine, Cardiology, Surgery +12